GO:2000802 positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000802 describes the biological process that activates or increases the frequency, rate, or extent of endocardial cushion to mesenchymal transition (EndoMT) specifically during heart valve formation.
• EndoMT is a specialized form of endothelial-to-mesenchymal transition in which endocardial cells delaminate, invade the cushion matrix, and differentiate into valve interstitial cells.
• Notch signaling, particularly via Manic Fringe (MFNG), is a key positive regulator of EndoMT during heart valve development.
• Disruption of EndoMT leads to congenital heart defects including bicuspid aortic valve (BAV) and outflow tract septation defects.
• CRISPR-based knockout, knock-in, and overexpression models are essential for dissecting the causal roles of genes that positively regulate EndoMT.
• Targeting positive regulators of EndoMT may offer therapeutic strategies for valve disease, though current evidence is primarily from developmental models [1,2].
Description
Heart valve formation is a precisely orchestrated developmental process that relies on the endocardial cushion to mesenchymal transition (EndoMT), a specialized endothelial-to-mesenchymal transition (EMT) occurring in the endocardial cushions of the developing heart. The Gene Ontology term GO:2000802, positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation, captures the regulatory events that enhance the frequency, rate, or extent of this transition. This process is critical for the proper cellularization of endocardial cushions, which subsequently remodel into mature valve leaflets and septa. Defects in EndoMT regulation are linked to congenital heart malformations such as bicuspid aortic valve (BAV) and outflow tract septation anomalies. Understanding the positive regulators of EndoMT is therefore essential for developmental biologists and clinicians studying valve disease. Recent studies have identified Notch signaling components, including Manic Fringe (MFNG), as positive regulators of EndoMT during heart valve development. These findings highlight the importance of GO:2000802 in both normal cardiogenesis and disease pathogenesis. Researchers investigating this term require robust experimental models to manipulate gene expression and assess functional outcomes. This article provides a comprehensive overview of the mechanisms, key genes, and research methodologies associated with GO:2000802, with a focus on CRISPR-based approaches for functional validation.
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation At A Glance
| GO ID | GO:2000802 |
|---|---|
| GO term | positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation |
| Ontology | biological_process |
| Synonym | positive regulation of endocardial cushion to mesenchymal transition involved in valve formation |
| Major function | Upregulation of the cellular transition that generates mesenchymal cells from endocardium during heart valve formation |
| Related process | Endocardial cushion to mesenchymal transition involved in heart valve formation (GO:0003199) |
| Regulatory direction | Positive (activating or increasing) |
| Taxonomic scope | Metazoa |
What Is GO:2000802?
GO:2000802 is a biological process term defined as any process that activates or increases the frequency, rate, or extent of endocardial cushion to mesenchymal transition involved in heart valve formation. In simpler terms, it encompasses all molecular and cellular events that positively regulate the transformation of endocardial cells into mesenchymal cells within the heart valve cushions, a critical step for valve development.
Why Is positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation Important in Cell Biology?
GO:2000802 is important because the positive regulation of EndoMT ensures adequate mesenchymal cell populations for proper heart valve formation. Insufficient EndoMT leads to hypoplastic valves and septation defects, while excessive or misregulated EndoMT may contribute to valve hyperplasia or stenosis. Understanding these regulatory mechanisms provides insights into congenital heart disease etiology and may inform regenerative strategies for valve repair [1,2].
• EndoMT is essential for cellularizing endocardial cushions, the precursors of heart valves and septa.
• Positive regulators of EndoMT, such as Notch signaling via MFNG, are required for normal valve development.
• Dysregulation of EndoMT is associated with bicuspid aortic valve (BAV) and outflow tract septation defects.
• GO:2000802 helps annotate genes that enhance EndoMT, facilitating functional genomics studies [1,2].
• Animal models, including the Syrian hamster, reveal conserved mechanisms of EndoMT regulation.
• CRISPR screening can identify novel positive regulators within this GO term.
• Understanding positive regulation may reveal therapeutic targets for valve disease.
• This term is critical for interpreting transcriptomic and proteomic data from developing hearts.
• It links developmental biology to clinical cardiology through congenital heart defect research.
• Studying GO:2000802 aids in deciphering gene regulatory networks in cardiogenesis.
What Happens During positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation?
Initiation of EndoMT by Positive Regulators
In simple terms: Certain signals tell endocardial cells to start changing into mesenchymal cells.
Positive regulation of EndoMT begins with signaling cues that activate endocardial cells within the cushion. Notch signaling, particularly through Manic Fringe (MFNG), has been shown to promote EndoMT during heart valve development. In the Syrian hamster model, endocardial-to-mesenchymal transition underlies outflow tract septation and bicuspid aortic valve formation, indicating that positive regulators are active in these regions. These signals increase the frequency and extent of the transition, as defined by GO:2000802.
Endocardial Cell Activation and Delamination
In simple terms: The activated cells loosen up and move away from their original layer.
Upon positive regulation, endocardial cells lose endothelial markers and gain mesenchymal characteristics. This process involves the disruption of cell-cell junctions and acquisition of migratory ability. Studies in hamster models demonstrate that EndoMT is crucial for outflow tract septation, and its positive regulation ensures sufficient mesenchymal cells for valve formation. MFNG-mediated Notch signaling promotes this transition, as evidenced by functional studies in heart valve development.
Invasion into the Cushion Matrix
In simple terms: The changed cells crawl into the jelly-like cushion to build valve tissue.
Following delamination, mesenchymal cells invade the endocardial cushion matrix. Positive regulators enhance the rate and extent of this invasion. In the Syrian hamster, EndoMT drives cellularization of cushions necessary for septation and valve formation. Notch pathway components, including MFNG, are implicated in promoting this invasive phase. The GO term GO:2000802 specifically covers processes that increase the frequency or rate of this transition.
Mesenchymal Differentiation and Valve Remodeling
In simple terms: The migrated cells mature and help shape the final valve structure.
Once in the cushion, mesenchymal cells differentiate into valve interstitial cells and contribute to remodeling. Positive regulation of EndoMT ensures an adequate pool of these cells. Disruption leads to defects such as bicuspid aortic valve, as observed in hamster models. MFNG and Notch signaling continue to influence these later stages, highlighting the sustained role of positive regulators.
Key Genes Involved in GO:2000802 positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
The following genes and proteins have been implicated in the positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MFNG | Promotes EndoMT via Notch signaling | Key positive regulator in heart valve development |
| NOTCH1 | Receptor in Notch signaling pathway | Central to EndoMT regulation |
| JAG1 | Notch ligand | Potential positive regulator of EndoMT |
| HEY1 | Notch target gene | Effector of Notch-mediated EndoMT |
| HEY2 | Notch target gene | Effector of Notch-mediated EndoMT |
| SNAI1 | Induces EMT transcription program | Downstream mediator of EndoMT |
| SNAI2 | Induces EMT transcription program | Downstream mediator of EndoMT |
| TWIST1 | Promotes mesenchymal phenotype | Associated with EndoMT |
| TGFB1 | Cytokine that can promote EndoMT | Potential positive regulator |
| BMP2 | Signaling molecule in cushion development | May enhance EndoMT |
| BMP4 | Signaling molecule in cushion development | May enhance EndoMT |
| VEGFA | Angiogenic factor | Can influence EndoMT |
| NFATC1 | Transcription factor in valve development | Downstream of EndoMT regulators |
| GATA4 | Transcription factor in cardiogenesis | Upstream regulator of EndoMT genes |
| TBX20 | Transcription factor in heart development | May modulate EndoMT |
| MEF2C | Transcription factor in heart development | Potential regulator |
| SOX9 | Transcription factor in valve development | Marker of mesenchymal cells |
How Is positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation Regulated?
The positive regulation of EndoMT is controlled by multiple signaling pathways. Notch signaling, activated by ligands such as JAG1 and modulated by MFNG, directly promotes EndoMT gene expression. TGF-beta and BMP signaling also contribute to EndoMT induction. These pathways converge on transcription factors like SNAI1/2 and TWIST1 that drive the mesenchymal phenotype. The Syrian hamster model has provided insights into how these regulators influence outflow tract septation and bicuspid aortic valve formation.
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MFNG | Bicuspid aortic valve, valve development | Knockout mouse, overexpression in zebrafish |
| NOTCH1 | Bicuspid aortic valve, calcific aortic valve disease | Knockout mouse, iPSC-derived endocardial cells |
| SNAI1 | EndoMT defects, congenital heart disease | Conditional knockout mouse |
| TGFB1 | Valve hyperplasia, Marfan syndrome | Overexpression mouse |
| BMP2 | Valve calcification | Knockout mouse |
Congenital Heart Defects: Bicuspid Aortic Valve
Disruption of EndoMT positive regulation leads to bicuspid aortic valve (BAV), a common congenital anomaly. In the Syrian hamster model, impaired EndoMT underlies BAV formation and outflow tract septation defects. This highlights the clinical importance of GO:2000802 in valve disease.
Outflow Tract Septation Defects
EndoMT is essential for outflow tract septation. Positive regulators ensure adequate mesenchymal cells for septation. Hamster studies show that EndoMT defects cause septation anomalies, linking GO:2000802 to conotruncal heart defects.
Valve Stenosis and Regurgitation
Altered EndoMT regulation may contribute to valve stenosis or regurgitation later in life. While direct evidence is limited, the developmental origins of valve disease suggest that positive regulators of EndoMT are relevant to long-term valve function.
From positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate EndoMT? | Knockout model (e.g., CRISPR KO in mouse or cell line) |
| Does a specific point mutation in gene X affect EndoMT? | Point mutation knock-in model |
| Does overexpression of gene X enhance EndoMT? | Overexpression model (e.g., transgenic or viral) |
| Where and when is gene X expressed during EndoMT? | Tagged knock-in reporter model |
| What are the downstream targets of gene X in EndoMT? | RNA-seq after knockout or overexpression |
| Can we identify novel regulators of EndoMT? | CRISPR library screening in endocardial cells |
How to Study the positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify EndoMT-associated genes |
| ChIP-seq | Transcription factor binding sites | Map Notch target genes |
| Lineage tracing | Cell fate conversion | Track endocardial to mesenchymal transition |
| Immunofluorescence | Protein localization and expression | Validate EndoMT markers |
| CRISPR knockout screening | Gene function loss-of-function | Discover novel regulators |
| Western blot | Protein levels | Quantify mesenchymal markers |
| qRT-PCR | mRNA levels | Measure EndoMT gene expression |
Transcriptomic Profiling
RNA-seq of endocardial cells undergoing EndoMT can identify genes differentially expressed upon positive regulation. Comparing wild-type and mutant models reveals pathways controlled by regulators like MFNG.
Lineage Tracing and Imaging
Genetic lineage tracing using Cre-lox systems allows visualization of endocardial cells transitioning to mesenchymal fate. Confocal imaging of cushion explants can quantify invasion and migration.
CRISPR Screening
Pooled CRISPR knockout screens in endocardial cell lines or primary cells can identify novel positive regulators of EndoMT. Hits can be validated in vivo using animal models.
Protein-Protein Interaction Studies
Co-immunoprecipitation and mass spectrometry can uncover complexes involving Notch pathway components like MFNG during EndoMT.
How CRISPR Can Be Used to Study GO:2000802 positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
Knockout
CRISPR knockout of candidate positive regulators (e.g., MFNG) in endocardial cells or animal models can test their necessity for EndoMT. Loss of function may reduce mesenchymal cell numbers and impair valve formation.
Point Mutation
Introducing specific point mutations in genes like NOTCH1 can mimic human variants associated with valve disease. These models help dissect the impact of individual mutations on EndoMT regulation.
Knock-in
Knock-in of reporter tags (e.g., GFP) into endogenous loci allows real-time visualization of EndoMT regulators. This approach can track expression dynamics during valve development.
Overexpression
Overexpression of positive regulators such as MFNG can enhance EndoMT and may lead to valve hyperplasia. These models are useful for gain-of-function studies.
How EDITGENE Supports positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation Research
Researchers studying positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation-related genes often need to determine whether a candidate gene is causally involved in this process. EDITGENE provides comprehensive CRISPR-based services to accelerate such functional studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation research.
Frequently Asked Questions About positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
What is GO:2000802?
GO:2000802 is a Gene Ontology term for the biological process that positively regulates endocardial cushion to mesenchymal transition involved in heart valve formation.
What genes are involved in positive regulation of endocardial cushion to mesenchymal transition?
Key genes include MFNG, NOTCH1, JAG1, HEY1, HEY2, SNAI1, SNAI2, and TWIST1, among others [1,2].
How does Notch signaling regulate EndoMT?
Notch signaling, via Manic Fringe (MFNG), promotes EndoMT by activating target genes like HEY1 and HEY2 that drive mesenchymal transition.
What diseases are associated with defective EndoMT?
Defective EndoMT is linked to bicuspid aortic valve and outflow tract septation defects.
What model organisms are used to study EndoMT?
Mouse, zebrafish, and Syrian hamster models are commonly used, with the hamster providing insights into BAV.
How can CRISPR be used to study GO:2000802?
CRISPR knockout, knock-in, point mutation, and overexpression models allow functional dissection of positive regulators in EndoMT.
What is the difference between EndoMT and EMT?
EndoMT is a specialized EMT occurring in endocardial cells during heart valve formation, while EMT is a broader process in various tissues.
What are the markers of EndoMT?
Markers include loss of endothelial markers (e.g., CDH5) and gain of mesenchymal markers (e.g., SNAI1, TWIST1).
Can EndoMT be targeted therapeutically?
While primarily developmental, understanding EndoMT regulation may inform strategies for valve disease, though therapeutic targeting is not yet established [1,2].
What services does EDITGENE offer for EndoMT research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression models, library screening, and bioinformatics for EndoMT studies.
Conclusion
GO:2000802 represents a critical biological process in heart valve development, integrating signaling pathways that drive endocardial cushion to mesenchymal transition. Dysregulation of this process leads to congenital heart defects such as bicuspid aortic valve. Continued research using CRISPR-based models will uncover novel regulators and therapeutic targets. EDITGENE supports these efforts with comprehensive gene editing services.
References
- 1. Soto-Navarrete MT et al.. 2025. Endocardial-to-mesenchymal transition underlies cardiac outflow tract septation and bicuspid aortic valve formation in the Syrian hamster model.. Sci Rep 15(1):8583 PMID: 40074779
- 2. Yang J et al.. 2025. Manic Fringe promotes endothelial-to-mesenchymal transition mediated by the Notch signalling pathway during heart valve development.. J Mol Med (Berl) 103(1):51-71 PMID: 39528804
